How Much Does AndroGel Cost in Louisiana?

Louisiana Retail Pricing for AndroGel in 2026

The average cash price for a 30-day supply of branded AndroGel 1.62% at Louisiana retail pharmacies sits at approximately $510 in 2026. That figure matches AbbVie's manufacturer list price, which has remained stable since mid-2025.

Price variation across the state is minimal for the branded product. Pharmacies in New Orleans, Baton Rouge, Shreveport, and Lafayette all cluster within a few dollars of that $510 figure when no discount programs are applied. The reason: AbbVie sets a wholesale acquisition cost (WAC) that anchors retail pricing nationwide, and Louisiana pharmacies pass that cost through with standard dispensing margins.

Generic testosterone gel 1.62%, manufactured by companies including Teva and Perrigo, is available at considerably lower price points. Cash prices for generic versions typically range from $180 to $350 per month depending on the pharmacy and whether the patient uses a discount card. A 2020 analysis published in JAMA Internal Medicine found that generic topical testosterone formulations showed bioequivalence to branded products with no clinically meaningful difference in serum testosterone levels.

Patients filling at independent pharmacies occasionally find slightly lower generic pricing compared to national chains. Asking your pharmacist to run both branded and generic pricing before committing to a fill takes 60 seconds and can save hundreds.

Louisiana Medicaid and AndroGel Coverage

Louisiana Medicaid does not cover AndroGel. The state's Healthy Louisiana managed care plans, operated by carriers including Healthy Blue, Aetna Better Health, AmeriHealth Caritas, and UnitedHealthcare Community Plan, exclude branded testosterone gel from their preferred drug lists.

This exclusion affects a large population. Approximately 1.9 million Louisiana residents are enrolled in Medicaid or CHIP as of early 2026, according to CMS enrollment data. For men in that population diagnosed with hypogonadism, the exclusion forces a choice between paying out of pocket, switching to a covered formulation (such as injectable testosterone cypionate, which most Medicaid plans do cover), or pursuing compounded alternatives.

Injectable testosterone cypionate typically costs $30 to $80 per month even without insurance, making it the most affordable Medicaid-accessible option. The Endocrine Society's 2018 clinical practice guideline for testosterone therapy in men with hypogonadism lists both topical gel and intramuscular injection as first-line options, noting that the choice between them should account for patient preference, cost, and adherence patterns.

For Louisiana Medicaid enrollees who specifically need a topical formulation (needle phobia, preference for steady-state pharmacokinetics, or prior authorization denial of injectables), compounded testosterone gel from a 503A pharmacy at roughly $120 per month may be the most practical path.

Private Insurance Coverage in Louisiana

Commercial insurance plans in Louisiana cover AndroGel or its generic equivalent with varying degrees of generosity. The state's major carriers, including Blue Cross Blue Shield of Louisiana, UnitedHealthcare, Cigna, and Aetna, generally place branded AndroGel on Tier 3 (preferred brand) or Tier 4 (non-preferred brand) formularies.

A Tier 3 copay in Louisiana typically ranges from $50 to $100 per month. Tier 4 can push that to $100 to $200. Generic testosterone gel usually sits on Tier 2, with copays of $20 to $50. These numbers shift by employer plan design, so calling the number on the back of your insurance card remains the single most reliable way to get your actual cost.

Prior authorization is common. Most Louisiana commercial plans require documentation of two morning serum testosterone levels below 300 ng/dL (measured by a reliable assay) along with signs or symptoms of hypogonadism before approving coverage. The T-Trials, a coordinated set of seven randomized trials involving 790 men aged 65 and older, demonstrated that testosterone gel improved sexual function, physical function, and bone density over 12 months, findings that support medical necessity arguments on prior authorization appeals.

Patients whose commercial plans deny branded AndroGel should ask their prescriber to submit a formulary exception request citing clinical need. If the generic is covered, that switch alone can reduce monthly out-of-pocket costs by 40% to 65%.

AbbVie Savings Card and Patient Assistance

AbbVie offers a manufacturer savings card for AndroGel that can reduce out-of-pocket costs for commercially insured patients. The program is available to Louisiana residents with private insurance and may bring monthly copays to as low as $0, depending on plan design.

Key restrictions apply. The savings card is not available to patients covered by Medicare, Medicaid, TRICARE, or any other federal or state government payer program. That limitation exists because of federal anti-kickback statutes, which prohibit manufacturer copay support for government-funded prescriptions. For commercially insured patients, the card typically has an annual maximum benefit (often $3,600 to $4,800 per year) after which the patient reverts to their standard plan copay.

To activate the card, patients can visit AbbVie's product website or receive an activation code from their prescriber's office. The card is presented at the pharmacy along with the insurance card at each fill.

For uninsured patients or those whose income falls below certain thresholds, AbbVie also operates a Patient Assistance Program (PAP) that may provide branded AndroGel at no cost. Eligibility is typically pegged to income at or below 400% of the federal poverty level. Applications require prescriber involvement and income documentation.

GoodRx, RxSaver, and similar discount aggregators can also reduce cash-pay pricing for generic testosterone gel at Louisiana pharmacies. These programs do not stack with insurance but can beat insurance copays in some cases, particularly for patients on high-deductible health plans who have not yet met their annual deductible.

Compounded Testosterone Gel in Louisiana

Compounded testosterone gel is legal in Louisiana when dispensed by a licensed 503A compounding pharmacy pursuant to a valid patient-specific prescription. Louisiana follows FDA guidance under Section 503A of the Federal Food, Drug, and Cosmetic Act, which permits pharmacies to compound medications for individual patients when certain conditions are met.

A 503A pharmacy must compound based on a prescription for an identified patient, use ingredients that meet USP or NF standards, and not produce drug products that are essentially copies of commercially available drugs. There is a nuance here: compounded testosterone gel in custom concentrations (for example, 5% or 10% formulations not commercially available) generally qualifies, while compounding a direct copy of AndroGel 1.62% may face regulatory scrutiny.

Pricing for compounded testosterone gel in Louisiana averages approximately $120 per month, representing a 76% savings compared to branded AndroGel. Several 503A pharmacies operate in the state, concentrated in Baton Rouge, New Orleans, and the Acadiana region. Telehealth-connected compounding pharmacy networks also serve Louisiana patients, shipping compounded formulations directly to the patient's home.

A 2019 survey published in the Journal of the American Pharmacists Association found that compounded testosterone formulations varied in potency by up to 25% between pharmacies, underscoring the importance of choosing a pharmacy with PCAB (Pharmacy Compounding Accreditation Board) accreditation or similar quality credentials. Ask your compounding pharmacy for their most recent potency assay results before filling.

Telehealth Prescribing of Testosterone Gel in Louisiana

Louisiana permits telehealth prescribing of testosterone gel, including AndroGel and its generic equivalents. The Louisiana State Board of Medical Examiners requires that the prescribing provider hold an active Louisiana medical license or be authorized through an interstate compact.

Telehealth has expanded access for men in rural parts of the state where endocrinologists are scarce. According to HRSA data, 46 of Louisiana's 64 parishes are classified as medically underserved areas. For a man in, say, Avoyelles or Concordia parish, driving two hours to see an endocrinologist in Baton Rouge is a real barrier. Telehealth eliminates it.

The prescribing process via telehealth typically involves an initial video consultation, laboratory orders for serum total testosterone (drawn between 7 and 10 AM on two separate mornings), and a follow-up visit to review results and initiate therapy if indicated. The Endocrine Society guideline recommends confirming low testosterone on at least two morning samples before starting treatment, a standard that responsible telehealth platforms follow.

Louisiana does not require an in-person visit before initiating testosterone therapy via telehealth, although some platforms choose to require one for clinical thoroughness. Once prescribed, the medication can be filled at any Louisiana pharmacy or shipped from a licensed pharmacy in another state, provided that pharmacy holds a Louisiana non-resident pharmacy license.

Comparing AndroGel to Other Testosterone Formulations Available in Louisiana

AndroGel is one of several FDA-approved testosterone formulations, and cost-conscious patients in Louisiana should understand the alternatives before committing to the most expensive option.

Injectable testosterone cypionate remains the cheapest testosterone replacement therapy on the market. A 10 mL vial of 200 mg/mL (a roughly 10-week supply at standard dosing) costs $30 to $80 at Louisiana pharmacies. Injections are administered every 1 to 2 weeks, either in a clinic or via self-injection. The drawback: serum testosterone levels peak and trough in a sawtooth pattern, which some men experience as mood and energy fluctuations. A 2017 pharmacokinetic study showed that weekly subcutaneous testosterone cypionate injections produced more stable levels than biweekly intramuscular injections, an approach that is gaining clinical traction.

Testosterone patches (Androderm) offer transdermal delivery similar to gel but cost $400 to $600 per month and have higher rates of application-site skin reactions. Few Louisiana prescribers recommend patches as a first-line option given the cost and tolerability profile.

Nasal testosterone (Natesto) is a newer option, applied three times daily to the nasal mucosa. It costs $500 to $700 per month and has a less strong evidence base. Its primary advantage is a lower impact on spermatogenesis compared to other exogenous testosterone, which may matter for men who wish to preserve fertility.

Testosterone pellets (Testopel) are implanted subcutaneously every 3 to 6 months. Per-procedure costs including the office visit run $500 to $1,500 in Louisiana, but the convenience of infrequent dosing appeals to some patients. The FDA label for Testopel notes a pellet extrusion rate of approximately 8% to 12%.

For most Louisiana men whose primary concern is cost, injectable testosterone cypionate at $30 to $80 per month or compounded testosterone gel at $120 per month will be more sustainable than branded AndroGel at $510.

How to Reduce Your AndroGel Costs in Louisiana

Practical steps, listed from highest to lowest expected savings:

Switch to generic testosterone gel. If your prescriber writes for AndroGel by brand name, ask whether generic testosterone gel 1.62% is appropriate. For most patients, it is. Savings: $160 to $330 per month compared to branded.

Use the AbbVie savings card. If you have commercial insurance and prefer branded AndroGel, activate the manufacturer card. Savings: potentially $200 to $500 per month depending on your plan's copay.

Consider compounded testosterone gel. A Louisiana 503A pharmacy can compound testosterone gel for approximately $120 per month. Confirm the pharmacy's accreditation and potency testing protocols. Savings: approximately $390 per month compared to branded.

Run a discount card comparison. Before filling, check GoodRx, RxSaver, and SingleCare pricing at your preferred pharmacy. These free tools sometimes beat insurance copays for generic testosterone gel. Takes 30 seconds on your phone.

Ask about 90-day fills. Many pharmacies and insurance plans offer per-unit discounts for 90-day supplies compared to 30-day fills. If your insurance covers testosterone gel, a 90-day fill may save 10% to 20% on copays over a year.

Explore patient assistance. If your household income is below 400% of the federal poverty level ($62,400 for a single individual in 2026), AbbVie's Patient Assistance Program may provide branded AndroGel at no cost.

Monitoring Costs Beyond the Prescription

The medication itself is only part of the total cost of testosterone therapy. Louisiana patients should budget for monitoring labs and follow-up visits.

The Endocrine Society recommends checking serum testosterone levels 2 to 4 weeks after initiating gel therapy, then every 6 to 12 months once stable. A complete monitoring panel typically includes total testosterone, free testosterone, hematocrit, PSA (for men over 40), and a lipid panel.

Lab costs in Louisiana range from $0 (covered by most insurance plans as preventive or diagnostic) to $100 to $250 out of pocket through direct-to-consumer lab services such as Quest Diagnostics or Labcorp walk-in pricing. A hematocrit check is particularly important: testosterone therapy increases red blood cell production, and the FDA's class-wide labeling for testosterone products includes a warning about polycythemia risk. If hematocrit exceeds 54%, dose reduction or temporary cessation is standard practice.

Telehealth follow-up visits in Louisiana typically cost $50 to $150 per visit without insurance. Most patients need 2 to 4 visits per year once stabilized on therapy, adding $100 to $600 in annual follow-up costs. Factor these into your total cost-of-therapy calculation when comparing AndroGel ($6,120 per year at cash price) to injectable testosterone cypionate ($360 to $960 per year).